OBIO - Orchestra BioMed Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OBIO is currently covered by 4 analysts with an average price target of $14. This is a potential upside of $9.23 (257.14%) from yesterday's end of day stock price of $3.92.

Orchestra BioMed Holdings's activity chart (see below) currently has 18 price targets and 24 ratings on display. The stock rating distribution of OBIO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.73% with an average time for these price targets to be met of 13.78 days.

Highest price target for OBIO is $20, Lowest price target is $10, average price target is $14.

Most recent stock forecast was given by from HC WAINWRIGHT on 14-May-2026. First documented stock forecast 07-Feb-2023.

Best performing analysts who are covering OBIO - Orchestra BioMed Holdings:

Keay Nakae Matt O'brien Yi Chen Matt Miksic Marie Thibault

Currently out of the existing stock ratings of OBIO, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Aug-2024

$10

$5.76 (135.85%)

$10

1 months 25 days ago
(14-May-2026)

0/7 (0%)

$5.89 (143.31%)

Buy Since 07-Feb-2023

$20

$15.76 (371.70%)

$20

3 months 27 days ago
(12-Mar-2026)

1/7 (14.29%)

$15.62 (356.62%)

57

Buy Since 02-Jan-2025

$12

$7.76 (183.02%)

$11

6 months ago
(09-Jan-2026)

0/4 (0%)

$7.2 (150.00%)

Buy Since 20-Mar-2025

$12

10 months 19 days ago
(20-Aug-2025)

0/2 (0%)

$8.76 (270.37%)

Buy Since 24-Feb-2023

$15

$10.36 (223.28%)

$15

2 years 7 months 25 days ago
(14-Nov-2023)

1/2 (50%)

$8.17 (119.62%)

10

Show more analysts

Please expand the browser size to see the chart

What is OBIO (Orchestra BioMed Holdings) average time for price targets to be met?

On average it took 13.78 days on average for the stock forecasts to be realized with a an average price target met ratio 8.73

Which analyst has the current highest performing score on OBIO (Orchestra BioMed Holdings) with a proven track record?

KEAY NAKAE

Which analyst has the most public recommendations on OBIO (Orchestra BioMed Holdings)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 7 ratings on OBIO

Which analyst is the currently most bullish on OBIO (Orchestra BioMed Holdings)?

Keay Nakae with highest potential upside - $15.81

Which analyst is the currently most reserved on OBIO (Orchestra BioMed Holdings)?

Marie Thibault with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?